Upgrade to SI Premium - Free Trial

Piper Jaffray Reiterates Overweight Rating on Amgen (AMGN)

August 22, 2019 12:45 PM
Piper Jaffray analyst Christopher Raymond reiterated an Overweight rating and $210.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments

Next Articles